ACT see page 11 of 14

Page 3
Research and Growth: Strategy for UK Life Sciences
“The old ‘big pharma’ model is becoming more difficult to maintain.
In its place is a new focus on translational medicine - more early stage clinical trials with patients, more external innovation, more collaboration.”
“This is an ambitious strategy to:
• open up universities and business to more collaboration;
• invest in the best ideas at an early stage;
• remove regulatory barriers;
• open up the NHS to new innovations and new clinical trials.”